| Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review |
71 |
| Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS |
22 |
| Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings |
13 |
| Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride |
12 |
| The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity |
11 |
| Gadobutrol: A Review in Contrast-Enhanced MRI and MRA |
11 |
| Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab |
11 |
| Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features |
11 |
| Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database |
10 |
| West Syndrome: A Review and Guide for Paediatricians |
10 |
| Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece |
9 |
| Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution |
7 |
| Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors |
7 |
| Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience? |
7 |
| A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis |
7 |
| Cost-effectiveness Analysis of Pembrolizumab Plus Axitinib Versus Sunitinib in First-line Advanced Renal Cell Carcinoma in China |
7 |
| Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment |
7 |
| Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response? |
7 |
| Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015 |
7 |
| Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada |
6 |
| The Impact of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass on Intestinal Microbiota Differs from that of Laparoscopic Sleeve Gastrectomy in Japanese Patients with Obesity |
6 |
| Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades |
6 |
| A Review of Asenapine in the Treatment of Bipolar Disorder |
5 |
| Safety, Tolerability, and Pharmacokinetics of GDC- a Novel Na(V)1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers |
5 |
| Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus |
5 |
| Chronic Use of -Blockers and the Risk of Parkinson's Disease |
5 |
| Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury |
5 |
| Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects |
5 |
| Cardiovascular Toxicities with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Meta-Analysis of 77 Randomized Controlled Trials |
5 |
| The Respimat (R) Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients |
5 |
| Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial |
5 |
| A Literature Review of Psychotropic Medications and Alcohol as Risk Factors for Falls in Community Dwelling Older Adults |
5 |
| Effects of Sodium-glucose Cotransporter 2 Inhibitors on Amputation, Bone Fracture, and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Using an Alternative Measure to the Hazard Ratio |
5 |
| Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers |
5 |
| Pharmacokinetics of Imipenem in Critically Ill Patients with Life-threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation |
5 |
| Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT) |
4 |
| Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study |
4 |
| Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients |
4 |
| Emerging Trends in Metformin Prescribing in the United States from 2000 to 2015 |
4 |
| Combination of Omega-3 Fatty Acids and Valproic Acid in Treatment of Borderline Personality Disorder: A Follow-Up Study |
4 |
| Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Massand Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus |
4 |
| Cost Effectiveness of Daclatasvir Plus Asunaprevir Therapy for Chinese Patients with Chronic Hepatitis C Virus Genotype 1b |
4 |
| Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review |
4 |
| Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis |
4 |
| Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis |
4 |
| Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study |
4 |
| Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials |
4 |
| Benefits of Beta-Blockade in Sepsis and Septic Shock: A Systematic Review |
4 |
| Translating Benzodiazepine Utilization Data into Meaningful Population Exposure: Integration of Two Metrics for Improved Reporting |
4 |
| Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study |
4 |
